
SUPPLEMENTARY FIGURES: Figure S1: Methodology flow chart Figure S2: MTT assay showing cell viability for different drug concentrations and time points SUPPLEMENTARY TABLES: Table S1: Significantly regulated miRNAs (P-values < 0.05) with the respective fold change Table S2: The validated target genes (3' UTR binding, binding score ≥ 0.95) derived from miRwalk database Table S3: Validated miRNA target genes associated with Hypertension Table S4: Validated miRNA target genes and the side effects associated in terms of HPO database Table S5: Significantly differentially regulated proteins
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
